Prescription of psychotropic medication in patients with type two diabetes mellitus: A multi-practice study from Ireland

Background: Comorbid anxiety and depression and type two diabetes mellitus (T2DM) are commonly managed by General Practitioners (GPs). Objectives: To investigate the proportion of people with T2DM who are prescribed either antidepressant or benzodiazepine medications in general practice; to compare...

Full description

Bibliographic Details
Main Authors: Paul Keating, Ray O’Connor, Jane O’Doherty, Ailish Hannigan, Walter Cullen, Louise Hickey, Anne Harnett, David Meagher, Andrew O’Regan
Format: Article
Language:English
Published: Taylor & Francis Group 2019-07-01
Series:European Journal of General Practice
Subjects:
Online Access:http://dx.doi.org/10.1080/13814788.2019.1640208
_version_ 1818958728978759680
author Paul Keating
Ray O’Connor
Jane O’Doherty
Ailish Hannigan
Walter Cullen
Louise Hickey
Anne Harnett
David Meagher
Andrew O’Regan
author_facet Paul Keating
Ray O’Connor
Jane O’Doherty
Ailish Hannigan
Walter Cullen
Louise Hickey
Anne Harnett
David Meagher
Andrew O’Regan
author_sort Paul Keating
collection DOAJ
description Background: Comorbid anxiety and depression and type two diabetes mellitus (T2DM) are commonly managed by General Practitioners (GPs). Objectives: To investigate the proportion of people with T2DM who are prescribed either antidepressant or benzodiazepine medications in general practice; to compare people with T2DM that have a prescription with those that do not in terms of patient characteristics, glycaemic control and healthcare utilization. Methods: Anonymized data was collected by GPs and senior medical students from electronic medical records of patients with T2DM in 34 Irish general practices affiliated with the University of Limerick Graduate Entry Medical School during the 2013/14 academic year. Data included demographics, healthcare utilization, prescriptions and most recent glycosylated haemoglobin (HbA1c) measurement. Results: The sample included 2696 patients with T2DM, of which 733 (36.7%) were female, and with a median age of 66 years. The percentage with a current prescription for an antidepressant or benzodiazepine was 22% (95%CI: 18.9–24.9). Those with a current prescription for either drug were more likely to have attended the emergency department (28.3% vs 15.7%, P <0.001), to have been admitted to hospital (35.4% vs 21.3%, P <0.001) in the past year and attend their GP more frequently (median of 9 vs 7, P <0.001) than those without a prescription. Rates of poor glycaemic control were similar in those with and without a current prescription. Conclusion: Over one-fifth of people with T2DM in Irish general practice are prescribed an antidepressant or benzodiazepine medication. Prescription of these is associated with increased healthcare utilization but not poorer glycaemic control.
first_indexed 2024-12-20T11:30:22Z
format Article
id doaj.art-b4f2645af6874a3582251b6c7d37e7ee
institution Directory Open Access Journal
issn 1381-4788
1751-1402
language English
last_indexed 2024-12-20T11:30:22Z
publishDate 2019-07-01
publisher Taylor & Francis Group
record_format Article
series European Journal of General Practice
spelling doaj.art-b4f2645af6874a3582251b6c7d37e7ee2022-12-21T19:42:15ZengTaylor & Francis GroupEuropean Journal of General Practice1381-47881751-14022019-07-0125315716310.1080/13814788.2019.16402081640208Prescription of psychotropic medication in patients with type two diabetes mellitus: A multi-practice study from IrelandPaul Keating0Ray O’Connor1Jane O’Doherty2Ailish Hannigan3Walter Cullen4Louise Hickey5Anne Harnett6David Meagher7Andrew O’Regan8University of LimerickUniversity of LimerickUniversity of LimerickUniversity of LimerickUCDTrinity College DublinUniversity of LimerickUniversity of LimerickUniversity of LimerickBackground: Comorbid anxiety and depression and type two diabetes mellitus (T2DM) are commonly managed by General Practitioners (GPs). Objectives: To investigate the proportion of people with T2DM who are prescribed either antidepressant or benzodiazepine medications in general practice; to compare people with T2DM that have a prescription with those that do not in terms of patient characteristics, glycaemic control and healthcare utilization. Methods: Anonymized data was collected by GPs and senior medical students from electronic medical records of patients with T2DM in 34 Irish general practices affiliated with the University of Limerick Graduate Entry Medical School during the 2013/14 academic year. Data included demographics, healthcare utilization, prescriptions and most recent glycosylated haemoglobin (HbA1c) measurement. Results: The sample included 2696 patients with T2DM, of which 733 (36.7%) were female, and with a median age of 66 years. The percentage with a current prescription for an antidepressant or benzodiazepine was 22% (95%CI: 18.9–24.9). Those with a current prescription for either drug were more likely to have attended the emergency department (28.3% vs 15.7%, P <0.001), to have been admitted to hospital (35.4% vs 21.3%, P <0.001) in the past year and attend their GP more frequently (median of 9 vs 7, P <0.001) than those without a prescription. Rates of poor glycaemic control were similar in those with and without a current prescription. Conclusion: Over one-fifth of people with T2DM in Irish general practice are prescribed an antidepressant or benzodiazepine medication. Prescription of these is associated with increased healthcare utilization but not poorer glycaemic control.http://dx.doi.org/10.1080/13814788.2019.1640208Antidepressantsbenzodiazepineshealthcare utilizationprimary caretype two diabetes mellitus
spellingShingle Paul Keating
Ray O’Connor
Jane O’Doherty
Ailish Hannigan
Walter Cullen
Louise Hickey
Anne Harnett
David Meagher
Andrew O’Regan
Prescription of psychotropic medication in patients with type two diabetes mellitus: A multi-practice study from Ireland
European Journal of General Practice
Antidepressants
benzodiazepines
healthcare utilization
primary care
type two diabetes mellitus
title Prescription of psychotropic medication in patients with type two diabetes mellitus: A multi-practice study from Ireland
title_full Prescription of psychotropic medication in patients with type two diabetes mellitus: A multi-practice study from Ireland
title_fullStr Prescription of psychotropic medication in patients with type two diabetes mellitus: A multi-practice study from Ireland
title_full_unstemmed Prescription of psychotropic medication in patients with type two diabetes mellitus: A multi-practice study from Ireland
title_short Prescription of psychotropic medication in patients with type two diabetes mellitus: A multi-practice study from Ireland
title_sort prescription of psychotropic medication in patients with type two diabetes mellitus a multi practice study from ireland
topic Antidepressants
benzodiazepines
healthcare utilization
primary care
type two diabetes mellitus
url http://dx.doi.org/10.1080/13814788.2019.1640208
work_keys_str_mv AT paulkeating prescriptionofpsychotropicmedicationinpatientswithtypetwodiabetesmellitusamultipracticestudyfromireland
AT rayoconnor prescriptionofpsychotropicmedicationinpatientswithtypetwodiabetesmellitusamultipracticestudyfromireland
AT janeodoherty prescriptionofpsychotropicmedicationinpatientswithtypetwodiabetesmellitusamultipracticestudyfromireland
AT ailishhannigan prescriptionofpsychotropicmedicationinpatientswithtypetwodiabetesmellitusamultipracticestudyfromireland
AT waltercullen prescriptionofpsychotropicmedicationinpatientswithtypetwodiabetesmellitusamultipracticestudyfromireland
AT louisehickey prescriptionofpsychotropicmedicationinpatientswithtypetwodiabetesmellitusamultipracticestudyfromireland
AT anneharnett prescriptionofpsychotropicmedicationinpatientswithtypetwodiabetesmellitusamultipracticestudyfromireland
AT davidmeagher prescriptionofpsychotropicmedicationinpatientswithtypetwodiabetesmellitusamultipracticestudyfromireland
AT andreworegan prescriptionofpsychotropicmedicationinpatientswithtypetwodiabetesmellitusamultipracticestudyfromireland